# Isavuconazonium Sulfate for I.V. Infusion 200mg (クレセンバ点滴静注用２００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6179404D1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6179404D1029
- **Product name (Japanese):** クレセンバ点滴静注用２００ｍｇ
- **English title:** Isavuconazonium Sulfate for I.V. Infusion 200mg
- **Active ingredient:** イサブコナゾニウム硫酸塩
- **Active ingredient (INN):** Isavuconazonium Sulfate
- **Strength / unit:** ２００ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 61 Antibiotics (抗生物質製剤) › 617 Antifungal antibiotics (主としてカビに作用するもの)
- **Manufacturer:** Asahi Kasei Therapeutics (旭化成セラピューティクス)
- **NHI price (reference only):** JPY 27393 per ２００ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6179404D1029
- **JSON:** https://www.nifujipharma.com/api/drugs/6179404D1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Isavuconazonium%20Sulfate%20for%20I.V.%20Infusion%20200mg%20(%E3%82%AF%E3%83%AC%E3%82%BB%E3%83%B3%E3%83%90%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%92%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%206179404D1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Isavuconazonium Sulfate

- [Isavuconazonium Sulfate Capsules 100mg (クレセンバカプセル１００ｍｇ)](https://www.nifujipharma.com/drugs/6179003M1021) — １００ｍｇ１カプセル, Asahi Kasei Therapeutics
- [Isavuconazonium Sulfate Capsules 40mg (クレセンバカプセル４０ｍｇ)](https://www.nifujipharma.com/drugs/6179003M2028) — ４０ｍｇ１カプセル, Asahi Kasei Therapeutics